These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8212321)

  • 61. Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B.
    Hughes ZA; Starr KR; Scott CM; Newson MJ; Sharp T; Watson JM; Hagan JJ; Dawson LA
    Psychopharmacology (Berl); 2007 May; 192(1):121-33. PubMed ID: 17265079
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM; Kang TB; Hjorth S; Auerbach SB
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
    Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
    J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recent Developments on Future Antidepressant-related Serotonin Receptors.
    Amidfar M; Kim YK
    Curr Pharm Des; 2018; 24(22):2541-2548. PubMed ID: 30073919
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Balance between cortical 5-HT1A and 5-HT2 receptor function: hypothesis for a faster antidepressant action.
    Borsini F
    Pharmacol Res; 1994 Jul; 30(1):1-11. PubMed ID: 7831190
    [No Abstract]   [Full Text] [Related]  

  • 66. Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
    Murray F; Hutson PH
    Eur J Pharmacol; 2007 Aug; 569(1-2):41-7. PubMed ID: 17582397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuropharmacological and antidepressant-like effects of ZY-1408: A novel serotonin/norepinephrine reuptake inhibitor and serotonin receptor 2C antagonist.
    Gao N; Tiliwaerde M; Zheng W; Xiong J; Li X; Jin Z
    Neuropharmacology; 2021 Jan; 182():108376. PubMed ID: 33122031
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Biochemical profile of YM992, a novel selective serotonin reuptake inhibitor with 5-HT2A receptor antagonistic activity.
    Hatanaka K; Nomura T; Hidaka K; Takeuchi H; Yatsugi S; Fujii M; Yamaguchi T
    Neuropharmacology; 1996; 35(11):1621-6. PubMed ID: 9025110
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.
    Boothman LJ; Mitchell SN; Sharp T
    Neuropharmacology; 2006 May; 50(6):726-32. PubMed ID: 16434063
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action.
    Smolders I; Clinckers R; Meurs A; De Bundel D; Portelli J; Ebinger G; Michotte Y
    Neuropharmacology; 2008 May; 54(6):1017-28. PubMed ID: 18378264
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Anxiolytic effects of serotonin reuptake inhibitors and their mechanism of action].
    Hashimoto S
    Hokkaido Igaku Zasshi; 2000 Nov; 75(6):421-36. PubMed ID: 11193934
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 73. 3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors.
    Lovell PJ; Blaney FE; Goodacre CJ; Scott CM; Smith PW; Starr KR; Thewlis KM; Vong AK; Ward SE; Watson JM
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1033-6. PubMed ID: 17129726
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SSRIs target prefrontal to raphe circuits during development modulating synaptic connectivity and emotional behavior.
    Soiza-Reilly M; Meye FJ; Olusakin J; Telley L; Petit E; Chen X; Mameli M; Jabaudon D; Sze JY; Gaspar P
    Mol Psychiatry; 2019 May; 24(5):726-745. PubMed ID: 30279456
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of increased serotonin levels on [18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin.
    Udo de Haes JI; Cremers TI; Bosker FJ; Postema F; Tiemersma-Wegman TD; den Boer JA
    Neuropsychopharmacology; 2005 Sep; 30(9):1624-31. PubMed ID: 15827572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biochemical effects of antidepressant augmentation.
    Howland RH
    Arch Gen Psychiatry; 1995 Feb; 52(2):156. PubMed ID: 7848052
    [No Abstract]   [Full Text] [Related]  

  • 77. 5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI).
    Hjorth S; Auerbach SB
    Behav Brain Res; 1996; 73(1-2):281-3. PubMed ID: 8788519
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors' Behavioral and Neurochemical Effects.
    Munari L; Provensi G; Passani MB; Galeotti N; Cassano T; Benetti F; Corradetti R; Blandina P
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv045. PubMed ID: 25899065
    [TBL] [Abstract][Full Text] [Related]  

  • 79. 6-[2-(4-Aryl-1-piperazinyl)ethyl]-2H-1,4-benzoxazin-3(4H)-ones: dual-acting 5-HT1 receptor antagonists and serotonin reuptake inhibitors.
    Bromidge SM; Bertani B; Borriello M; Faedo S; Gordon LJ; Granci E; Hill M; Marshall HR; Stasi LP; Zucchelli V; Merlo G; Vesentini A; Watson JM; Zonzini L
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5653-6. PubMed ID: 18799312
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antidepressants targeting the serotonin reuptake transporter act via a competitive mechanism.
    Apparsundaram S; Stockdale DJ; Henningsen RA; Milla ME; Martin RS
    J Pharmacol Exp Ther; 2008 Dec; 327(3):982-90. PubMed ID: 18801947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.